Releases List Price of Proteus™ Platform Reiterates Proteus Development Program On Track for Year End 2026 Launch BRANFORD, Conn.–(BUSINESS WIRE)–Mar. 3, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the fourth quarter and full year ended December 31, […]
BRANFORD, Conn.–(BUSINESS WIRE)–Jan. 28, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and IDEX Health & Science, LLC., today announced they will partner on the development and manufacturing of the optics module for Quantum-Si’s novel proteomics platform, Proteus™. IDEX Health & Science, LLC is the global leader in life […]
Provides Update on the Company’s Innovation Roadmap & New Development Partnerships Highlights new Distribution Agreement with Avantor in the U.S. and Canada BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 21, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New […]
Sales Pipeline is Accelerating and New Kits Remain on Track for Q4 Launch BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 12, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights Reported revenue of $787,000 for the third quarter of […]
Screening protein variants of interest is an essential step when studying mechanism of disease or developing novel biotherapeutics. Current screening methods require either back-to-back design-build-test cycles or large arrayed screens using automation, which can lead to lengthy assay timelines, technical challenges, unwanted variability and unnecessary cost. Furthermore, traditional phage-display or yeast-display methods may not be […]
Sequencing proteins and correlating amino acid changes to biological function is critical to advancing our understanding of human health and disease. While genomic and transcriptomic data offer insights into potential genetic predispositions and quantify changes in gene expression levels, they do not reflect the immediate changes or responses occurring at the protein level, which are […]
Advances in protein identification and characterization are key to unlocking new discoveries in health and disease. In this video, discover how Platinum®, the next-generation protein sequencer is accelerating scientific exploration with an easy-to-use, end-to-end benchtop solution to bring the power of protein sequencing to every lab, everywhere.
Protein-level analyses are crucial to advancing human disease research. However, traditional proteomic methods often lack the accuracy, specificity and depth recorded at the genomic or transcriptomic level. The latest protein sequencing technology offers information-rich insights into the primary structure, interactions, and modifications of diverse proteins, supporting an understanding of biological function in human disease. This […]
Katherine Johnson, Senior Director of Product, discusses how the Platinum® next-generation protein sequencer can not only directly sequence proteins with single amino acid resolution but can screen for hundreds of variants using protein barcoding. This combination of single-molecule sequencing and protein barcodes promises ground breaking insights into disease prevention and treatment strategies previously challenging with […]
Next-gen protein sequencing (NGPS) on Platinum enables protein identification and characterization with single-molecule and single amino acid resolution in a simple workflow using a benchtop instrument. Platinum Analysis Software workflows make peptide alignment and protein mapping easy to interpret without the need for advanced expertise. The output files from Platinum Analysis Software provide researchers with […]